Medical Office Intervention for Adolescent Drug Use

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

42 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-02-28

Study Completion Date

2008-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will use the CCPT II to assess attention in 12-21 year olds enrolled in a randomized controlled trial of a brief behavioral treatment for substance abuse.

This study will describe at baseline levels of attention using a well validated instrument (Connors Continuous Performance Test II) and explore the association between attention levels and substance use. The primary study hypothesis is that lower initial levels of substance use (as measured by percent days abstinent) will be associated with higher attention levels. We envision that this data will inform a better understanding of how attention may modify treatment response.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Medical Office Intervention for Adolescent Drug Use

NCT00229983

Substance-Related Disorders

COMPLETED PHASE2

Mentored Clinical Career Award in Adolescent Substance Abuse

NCT00622219

Substance-Related Disorders

COMPLETED NA

Cognitive Stimulation in Adolescents

NCT01948674

Substance Use Disorders

COMPLETED PHASE2

Field Trial of a Relapse Prevention Program for Adolescents Receiving Substance Use Treatment

NCT02125539

Substance-Related Disorders

COMPLETED PHASE2

Screening and Brief Intervention for Substance Misuse Following Traumatic Brain Injury

NCT02129361

Traumatic Brain Injury

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Research among adolescents with substance use problems presents unique challenges to investigators. Issues with recruitment, confidentiality, and follow-up have been cited as common limitations to research in this area. One likely contributor to decreased treatment persistence and follow-up is the limited ability to sustain attention that many adolescents, especially those with substance problems, may manifest. (Taper, 2002) Thus, assessing attention before beginning substance abuse treatment has the potential not only to inform the science of adolescent addiction medicine, but also to guide the development of therapies to specifically address attention deficits among adolescent substance users. Adolescent outpatients being treated for substance problems have not been systematically studied for clinical or subclinical attention levels.

The primary aims this study are as follows:

1. To test the feasibility of administering the Connors Continuous Performance Test II (CCPT II), a well validated measure of attention, to a sample of 12-21 year old patients receiving treatment for substance abuse.
2. To obtain baseline descriptive statistics on the CCPT II in a previously understudied group of young patients receiving treatment for substance abuse.
3. To estimate the magnitude of the association between substance use and levels of attention at baseline before treatment.
4. To explore the degree to which attention may affect response to substance abuse treatment in general and specifically motivational interviewing.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Substance-related Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Participants in this study will be 12-21 year old patients who have been referred to the Adolescent Substance Abuse Program for evaluation of drug or alcohol use and are participating in the parent study, "Medical Office Intervention for Adolescent Drug Abuse."

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* CRAFFT score of 1 or more
* Have used cannabis, alcohol or another drug on at least two occasions during the 30 days preceding their visit
* Can read and understand English

Exclusion Criteria

* Require immediate hospitalization or referral to residential substance abuse treatment
* Will not be available to complete the study assessments over the next 9 months.

Minimum Eligible Age

12 Years

Maximum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No